Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

Inclusion Criteria: * operable Stage IB2/II Cervical Cancer * adenocarcinoma, squamous cell or adenosquamous carcinoma * Patient between 18 and 70 years old * No lombo-aortic lymph node invasion at baseline * Previous 45 grays external pelvic radiation with concomitant chemotherapy (cisplatin 40 mg/m2/week corresponding to 5 cycles) * Followed by a 15 grays utero-vaginal brachytherapy, eventually combined with a 6th cycle of chemotherapy (cisplatin 40 mg/m2) * with a pelvic boost if lymph node or parametrial invasion * No macroscopic residual tumor after 6 to 8 weeks after brachytherapy. Exclusion Criteria: * Other tumor histology (neuro-endocrine) * Stage \> II (FIGO 1995) at baseline * Patient with remaining cervical cancer (after sub-total hysterectomy)